As part of the output from BioPALS and fragment based drug discovery (FBDD) cascades, we create focused libraries and perform screening to validate your hits.
We select assays from a portfolio of biochemical, biophysical, cellular and ADMET assays that meet your needs:
Biochemical screening uses purified enzymes, receptors, or other biomolecules to assess how a compound influences specific biochemical reactions
Biophysical screening complements biochemical methods by providing insights into the physical properties of drug-target interactions.
Cellular screening involves evaluating the effects of potential drug candidates within a cellular context, providing a more physiologically relevant assessment of drug activity.
For ADMET we have a diverse range of over 30 in vitro assays covering physicochemical properties, distribution, metabolism, and drug interactions, with a swift 5-day turnaround time for routine assays.